| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Unité de Recherches sur lEndocrinologie du Développement, INSERM, U-493, Département de Biologie, Ecole Normale Supérieure (L.M.-Z., L.G., C.B., M.D., S.I., J.-Y.P., N.J., N.d.C.), 92120 Montrouge, France; INSERM, U-10, Hôpital Bichat (L.L.), 75018 Paris, France; and Department of Pediatrics, Addenbrookess Hospital (I.A.H.), Cambridge, United Kingdom CB2 2QQ
Address all correspondence and requests for reprints to: Dr. Nathalie di Clemente, Unité de Recherches sur lEndocrinologie du Développement, INSERM, U-493, Département de Biologie, Ecole Normale Supérieure, 92120 Montrouge, France. E-mail: clemente{at}wotan.ens.fr
Abstract
Anti-Müllerian hormone belongs to the TGFß family whose members exert their effects by signaling through two related serine/threonine kinase receptors. Mutations of the anti-Müllerian hormone type II receptor occur naturally, causing the persistent Müllerian duct syndrome. In a family with two members with persistent Müllerian duct syndrome and one normal sibling, we detected two novel mutations of the anti-Müllerian hormone type II receptor gene. One, transmitted by the mother to her three sons, is a deletion of a single base leading to a stop codon, causing receptor truncation after the transmembrane domain. The other, a missense mutation in the substrate-binding site of the kinase domain, is transmitted by the father to the two sons affected by persistent Müllerian duct syndrome, indicating a recessive autosomal transmission as in other cases of persistent Müllerian duct syndrome. Truncating mutations in receptors of the TGFß family exert dominant negative activity, which was seen only when each of the mutant anti-Müllerian hormone receptors was overexpressed in an anti-Müllerian hormone-responsive cell line. We conclude that assessment of dominant activity in vitro, which usually involves overexpression of mutant genes, does not necessarily produce information applicable to clinical conditions, in which mutant and endogenous genes are expressed on a one to one basis.
This article has been cited by other articles:
![]() |
C. Belville, J.-D. Marechal, S. Pennetier, P. Carmillo, L. Masgrau, L. Messika-Zeitoun, J. Galey, G. Machado, D. Treton, J. Gonzales, et al. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport Hum. Mol. Genet., August 15, 2009; 18(16): 3002 - 3013. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome J Androl, January 1, 2009; 30(1): 46 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |